Yes, Ozempic and other GLP-1 medications like Wegovy and Zepbound can cause significant muscle loss, especially in women over 40 who are already more prone to losing lean mass due to hormonal shifts and age-related sarcopenia
This publicly available tool provides data about the insurance coverage of obesity treatments by state, including bariatric surgery and GLP-1 medications for most types of insurance coverage
Baker, PhD, Professor, Internal Medicine and Public Health Sciences and Associate Director, Wake Forest Alzheimers Disease Research Center at the Wake Forest University School of Medicine
There are no cancellation fees and no long-term contracts
The top companies in this segment include Novo Nordisk, Eli Lilly, Merck, Sanofi, AstraZeneca and Boehringer Ingelheim
Beyond the brain, these medications perform a vital dual role in your metabolic system